Bexion Pharmaceuticals
PrivateLast Round
Grant
Nov 14, 2024
Total Funding Raised
$10.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bexion Pharmaceuticals is a biotechnology company developing biologic therapies that target sphingolipid metabolism to treat solid tumors and chemotherapy-induced peripheral neuropathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bexion Pharmaceuticals Comparables
Compare Bexion Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 80% | |
| Apogee Biotechnology Corporation | 80% | |
| Vigeo Therapeutics | 77% | |
Bexion Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 14, 2024 | ||||
| Debt | Feb 4, 2021 | ||||
| Debt | Apr 13, 2020 | ||||
| Series B | Apr 30, 2019 | ||||
| Grant | Oct 13, 2013 | ||||
Grant | Mar 20, 2012 |
Bexion Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Keyhorse Capital | Series A |
| QCA Ventures | Series A |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Kentucky Cabinet for Economic Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 181% MoM, reaching 1.7K.
- Jan 8, 2025
Will present at the ASCO GI 2025 event.
Bexion Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bexion Pharmaceuticals's valuation, stock price, and market status.